How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research
Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction
CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis
Adenosine and adenosine receptor-mediated action in coronary microcirculation
MINOCA: a heterogenous group of conditions associated with myocardial damage
Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar
Initial Invasive or Conservative Strategy for Stable Coronary Disease
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.